PRASAD SUYASH

TSHA

PRASAD SUYASH serves as CMO and Head of R&D at Taysha Gene Therapies, Inc. (TSHA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$2.02M

Net Position

Net Seller

$2.02M

Companies Traded

TSHA

Active Period

Jul 2021 – Jul 2022

3 total trades

Most Recent

Sell TSHA

Jul 7, 2022 · $47.6K

PRASAD SUYASH's Insider Trading at Taysha Gene Therapies, Inc. (TSHA)

Buys

0 · $0.00

Sells

3 · $2.02M

Total Shares Bought

Total Shares Sold

142,000

TSHA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 7, 2022	Sell	12,861	$3.70	$47.6K	539,545
Jul 1, 2022	Sell	50,139	$3.65	$183.1K	581,265
Jul 1, 2021	Sell	79,000	$22.63	$1.79M	637,533

Related Insiders

Kamran Alam

CHIEF FINANCIAL OFFICER

TSHASell · Feb 4, 2026

Sukumar Nagendran

President and Head of R&D

TSHASell · Jan 23, 2026

Sean P. Nolan

Chief Executive Officer

TSHASell · Jan 23, 2026

Paul B Manning

10% Owner

TSHABuy · May 30, 2025

Explore More Insider Trading Data

TSHA Insider Trading Activity

View all insider trades at Taysha Gene Therapies, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity